- Home
- PLCE vs IKT Comparison
PLCE vs IKT Comparison
Compare PLCE & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLCE
- IKT
- Stock Information
- Founded
- PLCE 1969
- IKT 2008
- Country
- PLCE United States
- IKT United States
- Employees
- PLCE N/A
- IKT N/A
- Industry
- PLCE Clothing/Shoe/Accessory Stores
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- PLCE Consumer Discretionary
- IKT Health Care
- Exchange
- PLCE Nasdaq
- IKT Nasdaq
- Market Cap
- PLCE 169.6M
- IKT 140.5M
- IPO Year
- PLCE 1997
- IKT 2020
- Fundamental
- Price
- PLCE $6.98
- IKT $1.56
- Analyst Decision
- PLCE Hold
- IKT Buy
- Analyst Count
- PLCE 1
- IKT 2
- Target Price
- PLCE $7.00
- IKT $8.00
- AVG Volume (30 Days)
- PLCE 873.8K
- IKT 90.9K
- Earning Date
- PLCE 09-05-2025
- IKT 08-14-2025
- Dividend Yield
- PLCE N/A
- IKT N/A
- EPS Growth
- PLCE N/A
- IKT N/A
- EPS
- PLCE N/A
- IKT N/A
- Revenue
- PLCE $1,338,867,000.00
- IKT N/A
- Revenue This Year
- PLCE N/A
- IKT N/A
- Revenue Next Year
- PLCE $1.47
- IKT N/A
- P/E Ratio
- PLCE N/A
- IKT N/A
- Revenue Growth
- PLCE N/A
- IKT N/A
- 52 Week Low
- PLCE $3.66
- IKT $1.12
- 52 Week High
- PLCE $19.74
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- PLCE 69.16
- IKT 41.99
- Support Level
- PLCE $4.92
- IKT $1.50
- Resistance Level
- PLCE $7.85
- IKT $1.73
- Average True Range (ATR)
- PLCE 0.58
- IKT 0.10
- MACD
- PLCE 0.29
- IKT -0.02
- Stochastic Oscillator
- PLCE 75.35
- IKT 15.08
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.